Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases.
CONCLUSION: new perspectives emerge from the growing knowledge, bringing innovative techniques combining the action of Cxb with other substances or agents which act in a different way, but complementary, increasing the efficacy and minimizing toxicity.
PMID: 29714143 [PubMed - as supplied by publisher]
Source: Current Cancer Drug Targets - Category: Cancer & Oncology Authors: Quinones OG, Pierre MBR Tags: Curr Cancer Drug Targets Source Type: research
More News: Cancer | Cancer & Oncology | Celebrex | Colon Cancer | Colorectal Cancer | Dermatology | Gastroenterology | Oral Cancer | Skin | Skin Cancer | Toxicology